Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A high-profile insider move hits Impinj as a director sells 33,000 impinj shares. Learn what this signals, how to ana...
SpaceX is lining up a blockbuster IPO that could outpace the entire 2025 IPO slate. Analysts estimate a multi-billion...
When CODA reports its Q2 2026 results, the focus shifts from headlines to signals—backlog, margins, and customer wins...
Kinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
A single company dominates a crucial industry, changing the odds for investors. This piece breaks down what taiwan se...
JetBlue Airways sparked a rally as reports surfaced about a strategic review, including a possible sale. Here’s what ...
Worthington Steel stock dropped today after the company reported solid revenue growth but weak earnings due to higher...
SoundHound AI is chasing a $140 billion total addressable market. This article breaks down what that TAM means for in...
Nvidia shares jumped after U.S. officials cleared exports of advanced AI processors to Chinese firms, sparking a rall...
Discover how to read gamesquare (game) 2026 earnings and what the numbers could say about the company’s growth, profi...
A quiet SEC filing reveals a larger stake in Par Pacific. Explore what forest avenue capital adds means for investors...